Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Strategic Crispr & Gene Editing Technology ETF (XDNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

ETF Comparison for [[ item.sessionDateDisplayLong ]]

Results

Want to compare other data? Select Fields

Symbol	XDNA
Company	Strategic Crispr & Gene Editing Technology ETF
Price Information
Exchange	NASDAQ
Open	7.53
High	7.53
Low	7.38
Latest	7.38
Change	-0.12
% Change	-1.60%
Volume	4,200
20-Day Average Volume	6,940
Previous Close	7.50
Industry	N/A
Has Options	No
Technicals
20-Day Moving Average	7.16
20-Day Raw Stochastic	72.28%
20-Day Relative Strength	52.94
Weighted Alpha	-36.52
Today's Opinion	40% Sell
Previous Opinion	40% Sell
Last Month's Opinion	100% Sell
Performance
5-Days
%Chg	-2.45% since 11/22/23
Low	7.38 on 11/30/23
High	7.80 on 11/29/23
1-Month
%Chg	+22.59% since 10/30/23
Low	6.10 on 10/31/23
High	7.80 on 11/29/23
3-Month
%Chg	-12.46% since 08/30/23
Low	5.87 on 10/30/23
High	8.41 on 09/12/23
6-Month
%Chg	-19.43% since 05/30/23
Low	5.87 on 10/30/23
High	9.81 on 07/13/23
Key Statistics
Market Capitalization, $K	2,214
Shares Outstanding, K	300
Annual Sales	0
Annual Net Income	0
Last Quarter Sales	N/A
Last Quarter Net Income	N/A
60-Month Beta	0.92
Per-Share Information
Most Recent Earnings	N/A
Latest Earnings Date	N/A
Most Recent Dividend	N/A
Next Ex-Dividends Date	12/22/22
Ratios
Price/Earnings ttm	N/A